Form D Explorer

Inspect source fieldsReport a record issue

Form D — Epicrispr Biotechnologies, Inc.

0002151604-26-000001 · filed Aug 26, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
06b
Reported offering amount
$212,755,230
Reported amount sold
$176,754,406
Minimum investment
$0
Investors
47
Sales commission
$0
Finders' fees
$0

Issuer

Name
Epicrispr Biotechnologies, Inc.
CIK
2151604
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
7000 SHORELINE COURT, STE 100
SOUTH SAN FRANCISCO, CA 94080
Phone
510-934-7574

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗